Freelite Serum Free Light Chain Assays

This site is for Healthcare Professionals only

Click here for Patient Information
 

Latest News Headlines

 

Freelite is a major breakthrough for the detection and monitoring of Multiple Myeloma (MM) and other B-cell dyscrasia. There is now significant clinical evidence indicating the benefit of serum free light chain assays in initial screening for monoclonal gammopathies, identifying AL amyloidosis and Nonsecretory MM patients missed by conventional electrophoretic methods, as a prognostic indicator for progression in myeloma*, for risk stratification of MGUS patients* and rapid evaluation of treatment efficacy.

Freelite assays were developed by Binding Site to measure free lambda and free kappa immunoglobulin light chains. Our expertise in the manufacture of antibodies has enabled us to provide a quantifiable, highly specific, automatable free light chain assay for serum.

Review the clinical evidence for the utility of Freelite in detecting and monitoring plasma cell disorders and compare the results from laboratory protocols with and without Freelite.

* In the USA diagnostic use of this product is restricted to those stated in the product insert

See what the Hevylite ratio offers you 


Latest News 01 July 2009

Automated Analyser for Serum/Plasma Protein Analysis

SPAPLUSThe SPAPLUS™ is a dedicated serum and plasma protein analyser supplied by Binding Site. This compact, easy to use turbidimetric analyser provides a level of functionality usually seen only in larger analysers. The combination of an air mixing system, dual compartment reaction cuvettes and a hot water wash make the SPAPLUS ideal for Binding Site's latex assays. Other features include an automatic antigen excess check, automated rerun and autodilution capability plus Windows®-based software and bidirectional interface.

SPAPLUS assays currently include:
- Freelite™ serum free light chain assays
- IgG subclasses (IgG1 - IgG4)
- IgG, IgA, IgM
- Cystatin C
- ß2 Microglobulin
- Tetanus toxoid

Assays in development include Hevylite, IgA subclasses and IgD.
SPAPLUS is currently available in UK, USA, Canada, France, Germany, Austria and Spain. In other countries please check with your local Binding Site supplier. More